These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 24929172)

  • 1. Dose escalation, not “new biology,” can account for the efficacy of stereotactic body radiation therapy with non-small cell lung cancer. In reply to Rao et al.
    Brown JM; Carlson DJ; Brenner DJ
    Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):693-4. PubMed ID: 24929172
    [No Abstract]   [Full Text] [Related]  

  • 2. Dose escalation, not “new biology,” can account for the efficacy of stereotactic body radiation therapy with non-small cell lung cancer. In regard to Brown et al.
    Rao SS; Oh JH; Jackson A; Deasy JO
    Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):692-3. PubMed ID: 24929171
    [No Abstract]   [Full Text] [Related]  

  • 3. Dose escalation, not "new biology," can account for the efficacy of stereotactic body radiation therapy with non-small cell lung cancer.
    Brown JM; Brenner DJ; Carlson DJ
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1159-60. PubMed ID: 23517805
    [No Abstract]   [Full Text] [Related]  

  • 4. Stereotactic ablative radiation therapy for centrally located recurrences of non-small cell lung cancer: in regard to Chang et al.
    Oskan F
    Int J Radiat Oncol Biol Phys; 2014 Aug; 89(5):1141-1142. PubMed ID: 25035222
    [No Abstract]   [Full Text] [Related]  

  • 5. [Stereotactic body radiation therapy for early non-small cell lung cancer].
    Zhang HQ; Li MH; Yu JM
    Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):561-3. PubMed ID: 22325212
    [No Abstract]   [Full Text] [Related]  

  • 6. Pattern of failure following chemoradiation for locally advanced non-small cell lung cancer: potential role for stereotactic body radiotherapy.
    Nguyen NP; Bishop M; Borok TJ; Welsh J; Hamilton R; Cohen D; Nguyen LM; Vincent VH
    Anticancer Res; 2010 Mar; 30(3):953-61. PubMed ID: 20393019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic radiation therapy: changing treatment paradigms for stage I nonsmall cell lung cancer.
    Palma D; Senan S
    Curr Opin Oncol; 2011 Mar; 23(2):133-9. PubMed ID: 21107257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic body radiation therapy for inoperable lung cancer.
    Rusthoven KE; Pugh TJ
    JAMA; 2010 Jun; 303(23):2354-5; author reply 2355. PubMed ID: 20551403
    [No Abstract]   [Full Text] [Related]  

  • 9. Stereotactic radiosurgery for early stage non-small cell lung cancer: rationale, patient selection, results, and complications.
    Christie NA; Pennathur A; Burton SA; Luketich JD
    Semin Thorac Cardiovasc Surg; 2008; 20(4):290-7. PubMed ID: 19251167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sublobar/wedge resection or stereotactic body radiation therapy for stage I marginally operable non-small-cell lung cancer.
    Suppiah S; Linden P; Robke J; Schroeder C; Yao M; Machtay M; Lo SS
    Expert Rev Anticancer Ther; 2012 Nov; 12(11):1375-7. PubMed ID: 23249103
    [No Abstract]   [Full Text] [Related]  

  • 11. Stereotactic body radiation therapy (stereotactic ablative radiotherapy) for stage I non-small cell lung cancer--updates of radiobiology, techniques, and clinical outcomes.
    Hadziahmetovic M; Loo BW; Timmerman RD; Mayr NA; Wang JZ; Huang Z; Grecula JC; Lo SS
    Discov Med; 2010 May; 9(48):411-7. PubMed ID: 20515609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer.
    Aridgides P; Bogart J
    Thorac Surg Clin; 2016 Aug; 26(3):261-9. PubMed ID: 27427521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic Body Radiotherapy and Ablative Therapies for Lung Cancer.
    Abbas G; Danish A; Krasna MJ
    Surg Oncol Clin N Am; 2016 Jul; 25(3):553-66. PubMed ID: 27261915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic body radiation therapy as a derivative of stereotactic radiosurgery: clinically independent but with enduring common themes.
    Kavanagh BD
    J Clin Oncol; 2014 Sep; 32(26):2827-31. PubMed ID: 25113758
    [No Abstract]   [Full Text] [Related]  

  • 15. Stereotactic radiosurgery for lung tumors.
    Whyte RI
    Semin Thorac Cardiovasc Surg; 2010; 22(1):59-66. PubMed ID: 20813318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic body radiation therapy for lung cancer: achievements and perspectives.
    Hiraoka M; Matsuo Y; Takayama K
    Jpn J Clin Oncol; 2010 Sep; 40(9):846-54. PubMed ID: 20670962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Reply to Giron et al.
    Pepek JM; Christensen JD; Kelsey CR
    Pract Radiat Oncol; 2015; 5(5):e551. PubMed ID: 26362709
    [No Abstract]   [Full Text] [Related]  

  • 18. Dosimetric evaluation of heterogeneity corrections for RTOG 0236: stereotactic body radiotherapy of inoperable Stage I-II non-small-cell lung cancer. In reply to Dr. Xiao et al.
    Hurkmans CW; Cuijpers JP; Lagerwaard FJ; Widder J; van der Heide UA; Schuring D; Senan S
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):318; author reply 318. PubMed ID: 19695451
    [No Abstract]   [Full Text] [Related]  

  • 19. Stereotactic body radiation therapy in stage I inoperable lung cancer: from palliative to curative options.
    Boujelbene N; Elloumi F; Kamel ME; Abeidi H; Matzinger O; Mirimanoff RO; Khanfir K
    Swiss Med Wkly; 2013; 143():w13780. PubMed ID: 23740331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic body radiation therapy can be used safely to boost residual disease in locally advanced non-small cell lung cancer: a prospective study.
    Feddock J; Arnold SM; Shelton BJ; Sinha P; Conrad G; Chen L; Rinehart J; McGarry RC
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1325-31. PubMed ID: 23265574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.